4-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazole, 97%, 100mg

3-Amino-6-methoxypyridazine, 97.0%, 1g

2-Ethynyl-1,3-difluoro-5-((4-methoxybenzyl)oxy)benzene, 95+%, 250mg

(4-Bromo-3-fluorophenyl)(3,3-dimethylazetidin-1-yl)methanone, 95+%, 100mg

tri-sodium citrate dihydrate, min. 99% Ph.Eur., 500 g, plastic packaging.

2,3-Dihydro-1H-pyrrolo[2,3-c]pyridine hydrochloride, 95.0%, 10g

1-(4-methoxyphenyl)-2-(3-nitro-1H-pyrazol-1-yl)ethan-1-one, 95.0%, 1g

(2s)-3-Methyl-2-{[(propan-2-yloxy)carbonyl]amino}butanoic acid, 95+%, 100mg

2-(2-Fluoro-4-(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

2-(1-Amino-1-methylethyl)-N-(4-Fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide, 95.0%, 250mg

4,4',4'',4'''-(Ethene-1,1,2,2-tetrayl)tetrabenzaldehyde, 97.0%, 250mg

1-(DIMETHYLAMINO)-2-METHYLPROPAN-2-OL, 97.0%, 5g

3-Aminophenylacetic acid methyl ester, 95.0%, 10g